NEUROBiOGEN

본문 바로가기 주메뉴 바로가기

Comunications

NEUROBIOGEN has been working with an advisory network of researchers and clinical
experts specializing in brain & neurological diseases with long experience.

News

News
Notice

News

Here are news on NEUROBIOGEN (currently in Korean only).

NO	SUBJECT	DATE	VIEW
79	CNR Research, Neurobiogen U.S. FDA Pre-IND Contract.	2023. 10. 04	279
78	CNR Research "Neurobiogen Obesity Treatment Applies for FDA Pre-IND".	2023. 10. 04	287
77	CNR Research Signs U.S. Phase 2 Pre-IND Agreement With Neurobiogen.	2023. 10. 04	249
76	CNR Research Signs U.S. Phase 2 Pre-IND Promotion With NeuroBiogen.	2023. 10. 04	238
75	"You lose weight even if you eat the same amount".Domestic and foreign stock markets fluctuate due to the emergence of innovative obesity treatments.	2023. 09. 11	299
74	Obesity, diabetes medicine that can't be sold because it's not there...Pharmaceutical Bio to Develop New Drugs.	2023. 09. 08	280
73	Neurobiogen "Development of an innovative obesity drug that loses weight by eating without yo-yo and side effects."	2023. 09. 07	281
72	Losing weight while eating?What is the principle of the new drug candidate 'KDS2010'?	2023. 09. 04	276
71	Neurobiogen Posts 'Nature Metabolism' In Obesity Drug Study.	2023. 09. 01	288
70	"You lose weight even if you eat as much as you want."···Successful development of a new drug that removes only fat.	2023. 09. 01	273

1 2 3 4 5